RCAT(RCAT)
RCAT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E |
|---|---|
| Revenue Avg | $152M |
| Low | $152M |
| High | $152M |
| EBITDA Avg | $-149M |
| Low | $-149M |
| High | $-149M |
| EBIT Avg | $-151M |
| Low | $-151M |
| High | $-151M |
| Net Income Avg | $13M |
| Low | $13M |
| High | $13M |
| EPS Avg | $0.11 |
| Low | $0.11 |
| High | $0.11 |
| Analysts (Rev / EPS) | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $64M | $37M | $45M | $63M | $76M | $48M | $52M | $78M |
| Low | $56M | $32M | $40M | $55M | $67M | $42M | $45M | $68M |
| High | $80M | $47M | $57M | $79M | $96M | $60M | $65M | $98M |
| EBITDA Avg | $-62M | $-36M | $-45M | $-62M | $-75M | $-47M | $-51M | $-76M |
| Low | $-78M | $-46M | $-56M | $-77M | $-94M | $-59M | $-64M | $-96M |
| High | $-54M | $-32M | $-39M | $-54M | $-65M | $-41M | $-44M | $-67M |
| EBIT Avg | $-63M | $-37M | $-45M | $-63M | $-76M | $-48M | $-52M | $-78M |
| Low | $-79M | $-46M | $-57M | $-79M | $-95M | $-60M | $-65M | $-97M |
| High | $-55M | $-32M | $-39M | $-55M | $-66M | $-42M | $-45M | $-68M |
| Net Income Avg | $-17M | $-20M | $-19M | $-14M | $-9M | — | — | — |
| Low | $-22M | $-27M | $-25M | $-18M | $-12M | — | — | — |
| High | $-14M | $-17M | $-16M | $-11M | $-7M | — | — | — |
| EPS Avg | $-0.14 | $-0.17 | $-0.16 | $-0.11 | $-0.07 | — | — | — |
| Low | $-0.18 | $-0.22 | $-0.21 | $-0.15 | $-0.10 | — | — | — |
| High | $-0.11 | $-0.14 | $-0.13 | $-0.09 | $-0.06 | — | — | — |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / — | 1 / — | 1 / — |